Lanadelumab Biosimilar - Research Grade

Human

KLKB1

5mg/ml

Human IgG1 Kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P03952

Blue ice

Plasma kallikrein (KLKB1) is a serine protease that generates bradykinin and drives the contact activation pathway central to angioedema research. This anti-human plasma kallikrein recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of lanadelumab, provided strictly for research use only. Built to rigorous in vivo standards with a low-endotoxin profile, it is manufactured in scalable milligram (mg) to gram (g) quantities suited to bulk and high-throughput laboratories. It functions as a consistent inhibitory control and active reagent in protease-activity assays, in vitro functional screening, and in vivo models of contact-system activation and angioedema.

DX-2930,X124-G01,kallikrein B1, kallikrein B, plasma (Fletcher factor) 1, KLK3, Fletcher factor

Detects human KLKB1

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.